Burning Rock Biotech
86 hedge funds and large institutions have $491M invested in Burning Rock Biotech in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 11 closing their positions.
52% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 21
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
1% more funds holding
Funds holding: 85 → 86 (+1)
0.06% more ownership
Funds ownership: 3.09% → 3.15% (+0.06%)
38% less capital invested
Capital invested by funds: $794M → $491M (-$303M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$7.33M |
| 3 |
Morgan Stanley
New York
|
+$6.91M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$6.07M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$3.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$25.2M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$14.9M |
| 3 |
CCM
CloudAlpha Capital Management
Hong Kong
|
-$9.87M |
| 4 |
JP Morgan Chase
New York
|
-$2.76M |
| 5 |
ICP
Indus Capital Partners
New York
|
-$2.42M |
BNR Hedge Fund Activity: Q3 2021 in Review
86 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q3 2021, worth a combined $491M — down 38% from $794M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new BNR positions and 11 closed out — a net gain of 3 holders — while 32 added to existing stakes and 21 trimmed.
The largest buyer was Vanguard Group, adding an estimated $22M. The largest seller was Jennison Associates, cutting an estimated $25.2M.
- 86 institutional investors held Burning Rock Biotech (BNR) as of Q3 2021, up from 85 in Q2 2021.
- Funds reported $491M of Burning Rock Biotech stock for Q3 2021, down 38% quarter-over-quarter.
- 14 funds opened new Burning Rock Biotech positions in Q3 2021 and 11 closed out, a net change of +3 holders.
- The largest Burning Rock Biotech buyer in Q3 2021 was Vanguard Group, an estimated $22M added.
- The largest Burning Rock Biotech seller in Q3 2021 was Jennison Associates, an estimated $25.2M sold.
Based on aggregated 13F filings for Q3 2021.